Analytical Data
-
基因名
PSG6
- Application
-
别名
Pregnancy-specific beta-1-glycoprotein 6; PSBG-6; PSBG-10; CGM3; PSG10; PSG12; PSGGB
-
种属
Human
-
表达系统
Baculovirus
-
标签
C-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q00889-2
-
表达区间
Q35-H424
-
蛋白长度
Partial
-
分子量
58 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PSG6, or Pregnancy-Specific Glycoprotein 6, is part of a larger family of glycoproteins that play significant roles during pregnancy. These proteins are synthesized in the placenta and are believed to contribute to various physiological processes such as immune modulation, trophoblast invasion, and fetal development. Research on PSG6 has gained attention due to its potential implications in pregnancy-related disorders and its role in regulating maternal-fetal interactions. In particular, PSG6 has been linked to the suppression of maternal immune responses to protect the developing fetus from rejection, which is crucial given the genetic disparity between the mother and the fetus. Moreover, abnormalities in PSG expression levels have been associated with complications such as preeclampsia, fetal growth restriction, and miscarriage. Investigating the structural and functional characteristics of PSG6, as well as its interactions with other biomolecules, could provide insights into its precise role in placental physiology and pathology. Therefore, ongoing studies aim to elucidate the mechanisms underlying PSG6's function and its potential as a biomarker for monitoring pregnancy health, with the ultimate goal of improving maternal and fetal outcomes in clinical settings.
